You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三元生物(301206.SZ):在反傾銷調查期間出口至美國的金額為893.48萬美元,約佔公司營收的20.18%
格隆匯 02-06 15:50

格隆匯2月6日丨三元生物(301206.SZ)公佈,公司聘請的代理律師於近日已向美國商務部提交反傾銷調查相關問卷。現將相關進展情況公吿如下:

根據公司的初步測算,本次“雙反”涉案產品赤蘚糖醇(在美國協調關税表(HTSUS)中的分類為子目2905.49.4000和2106.90.9998。前述税則號僅供參考,產品是否涉案,具體應以產品範圍描述為準)在反傾銷調查期間(2024年4月1日-2024年9月30日)出口至美國的金額為893.48萬美元,約佔公司營業收入的20.18%。

本次對中國赤蘚糖醇的“雙反”尚處於調查階段,對公司生產、經營的影響存在不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account